Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2025-12-24 @ 5:34 PM
NCT ID:
NCT01807468
Eligibility Criteria:
Inclusion Criteria:
* age \< 21 years old
* Patients with high-risk solid tumors who failed prior HDCT/autoSCT
* Patients with a suitable haploidentical donor
* High-risk solid tumors include high-risk neuroblastoma, metastatic or relapsed Ewing sarcoma, relapsed osteosarcoma, high-risk brain tumors, relapsed germ cell tumors, relapsed soft tissue sarcoma, relapsed rhabdomyosarcoma, and etc.
* stable disease with salvage chemotherapy after relapse
Exclusion Criteria:
* organ dysfunction(NCI common toxicity criteria grade \> 2)
* progression of disease despite salvage chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
21 Years
Study:
NCT01807468
Study Brief:
Protocol Section:
NCT01807468